Property:Outcome specification
This is a property of type Text.
V
Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer +
No recurrence/SPT/death +
Van Zandwijk et al. (2000): EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer +
NI +
Villani et al. (2016): Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial +
Audiograms 2000/4000/8000 Hz and evoked brainstem responses +
Maximum severity of mucositis:
The clinical manifestation of mucositis was assessed in order to examine the side effects of radiation:
Stage I = erythema
Stage II = mucosaodema
Stage III = mucosal necrosis/ulceration +
First occurrence of mucositis after start of radiation therapy +
Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy +
Oxiplatin-based chemotherapy induced +
W
Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma +
Time between surgical treatment and recurrence of detectable disease +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Prophylaxis of xerostomia +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Ability to oral intake;
Amount of daily meals +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Objective tumor response to radiochemotherapy +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Prophylaxis of pain;
Reduction in the use of analgesics for the relief of oral pain +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Prevention of oral mucositis +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Prophylaxis of taste disturbance +
Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente +
'''Treatment success'''
Based on the radiological findings and quality of life (improved if general condition increased and radiological findings remain the same or improved) +
Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente +
'''Interaction with cancer treatment'''
Tolerance of cytostatic therapy/survival time (reference date 30 September 1977) regarding side effects and the infusions administered +
Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente +
Vitagramm: 4 qualities of life:
1. employable or able to work, free of complaints
2. care-free, only minor complaints
3. in need of care, more severe symptoms
4. bedridden and/or very severe discomfort +
Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer +
Breast cancer-specific QOL with FACT-B: physical, emotional, social, functional, breast cancer-specific concerns subscales and total scale +
Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer +
NA +
Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer +
Pain intensity with a single item from the Brief Pain Inventory-Short Form +
Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer +
Nausea with single item from the FACT-B physical subscale +